Observational study to assess treatment patterns and clinical outcome in advance and/or recurrent endometrial cancer after adjuvant chemotherapy
Not Applicable
- Conditions
- Endometrial cancer
- Registration Number
- JPRN-UMIN000050897
- Lead Sponsor
- JGOG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients deemed inappropriate as study subjects by the principal investigator and co-investigators 2) Patients who underwent radiation therapy or chemoradiotherapy after surgery (including external radiation therapy and brachytherapy, but palliative radiation therapy for pain relief to bones, brain, or other sites is allowed) 3) Patients who received preoperative treatment 4) Patients who underwent drug therapy with regimens other than cohorts A-C 5) Patients with concomitant active multiple cancers 6) Patients who are participating in clinical research involving interventions (including clinical trials) at the time of case registration.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The implementation rates of each drug therapy regimen in actual clinical practice and the progression-free survival periods by cohort for primary treatment after disease progression or recurrence following postoperative chemotherapy.
- Secondary Outcome Measures
Name Time Method